Product Information
GABAPENTIN 300 MG CAPSULE is a generic product labeled by Strides Pharma Inc., priced at $0.0301 per EA under NDC 64380075402. Its NADAC has been published 26 times since Feb 25, 2026.
FDA first approved this application on May 14, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380075402
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA206943FDA Approved
5/14/2018
TE Code
AB
On Market Since
1/8/2025
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 300 MG CAPSULE has been published 26 times since Feb 25, 2026, and over the history we have for it it has declined 9.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0301 per EA |
|---|---|
| All-time high | $0.0334 (Mar 11, 2026) |
| All-time low | $0.0301 (Aug 19, 2026) |
| 52-week high | $0.0334 |
| 52-week low | $0.0301 |
| Median price | $0.0325 |
| Average price | $0.0323 |
| Largest weekly change | -5.1% (Jul 22, 2026) |
| Weeks tracked | 26 |
| Tracking since | Feb 25, 2026 |
Generic Alternatives
The matcher finds 17 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of GABAPENTIN 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 300 MG CAPSULE, manufactured by Strides Pharma Inc., is $0.0301 per EA (NDC 64380075402), effective Aug 19, 2026.
How has the price of GABAPENTIN 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 300 MG CAPSULE has declined 9.8%. It has been tracked across 26 weekly CMS publications since Feb 25, 2026.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 300 MG CAPSULE?
Since Feb 25, 2026, the NADAC for GABAPENTIN 300 MG CAPSULE has ranged from a low of $0.0301 (Aug 19, 2026) to a high of $0.0334 (Mar 11, 2026), with a median of $0.0325 per EA.
Are there cheaper alternatives to GABAPENTIN 300 MG CAPSULE?
17 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GABAPENTIN 300 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures GABAPENTIN 300 MG CAPSULE?
GABAPENTIN 300 MG CAPSULE (NDC 64380075402) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.